DELLO SBARBA, PERSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.761
EU - Europa 8.257
AS - Asia 3.872
SA - Sud America 497
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 95
OC - Oceania 68
Totale 23.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.574
PL - Polonia 2.676
RU - Federazione Russa 2.069
IT - Italia 1.307
SG - Singapore 1.059
CN - Cina 840
HK - Hong Kong 600
SE - Svezia 566
IE - Irlanda 509
VN - Vietnam 456
BR - Brasile 373
KR - Corea 276
DE - Germania 248
FR - Francia 210
FI - Finlandia 192
IN - India 175
UA - Ucraina 169
GB - Regno Unito 145
JO - Giordania 114
CA - Canada 112
AU - Australia 67
BD - Bangladesh 60
JP - Giappone 60
AR - Argentina 46
CH - Svizzera 46
ID - Indonesia 46
TR - Turchia 46
CI - Costa d'Avorio 30
MX - Messico 27
EC - Ecuador 24
NL - Olanda 24
BE - Belgio 21
ES - Italia 21
ZA - Sudafrica 21
AT - Austria 17
IQ - Iraq 17
VE - Venezuela 17
CO - Colombia 16
TW - Taiwan 15
PK - Pakistan 14
CR - Costa Rica 12
TH - Thailandia 12
JM - Giamaica 10
MA - Marocco 10
AE - Emirati Arabi Uniti 8
MY - Malesia 8
PH - Filippine 8
RO - Romania 8
SA - Arabia Saudita 8
CL - Cile 7
UZ - Uzbekistan 7
EG - Egitto 6
NG - Nigeria 6
SC - Seychelles 6
IL - Israele 5
KE - Kenya 5
KW - Kuwait 5
KZ - Kazakistan 5
LT - Lituania 5
PE - Perù 5
TT - Trinidad e Tobago 5
AL - Albania 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LB - Libano 4
UY - Uruguay 4
BG - Bulgaria 3
BJ - Benin 3
DZ - Algeria 3
NP - Nepal 3
PR - Porto Rico 3
PY - Paraguay 3
SV - El Salvador 3
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GD - Grenada 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
MD - Moldavia 2
MM - Myanmar 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
GE - Georgia 1
GI - Gibilterra 1
IR - Iran 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
Totale 23.546
Salva come PNG Salva come JPEG
Città #
Warsaw 2.673
Santa Clara 2.033
Ashburn 1.228
Fairfield 795
Singapore 775
Chandler 614
Dublin 507
Hong Kong 491
Woodbridge 429
San Jose 397
Seattle 349
Cambridge 346
Jacksonville 313
Houston 294
Wilmington 275
Milan 274
Seoul 266
Beijing 249
Ann Arbor 204
Council Bluffs 189
Florence 177
Princeton 133
Buffalo 118
Los Angeles 117
Rome 113
Lauterbourg 112
Ho Chi Minh City 111
Boston 102
Lawrence 94
Boardman 92
Altamura 91
Dallas 90
Hanoi 86
Munich 81
The Dalles 80
Mumbai 79
Dong Ket 76
Shanghai 65
New York 64
Melbourne 63
Paris 62
Phoenix 62
San Diego 62
Moscow 59
Hefei 56
Tokyo 55
Chicago 51
Helsinki 48
Medford 48
Kent 46
São Paulo 43
Bern 42
Orem 40
Falls Church 39
Pune 36
Turku 35
Jakarta 33
Abidjan 30
Naples 29
Toronto 29
Redondo Beach 28
Columbus 27
Guangzhou 26
Turin 26
Norwalk 25
London 24
Bologna 23
Brussels 21
Figino 21
Clifton 20
Frankfurt am Main 19
Ottawa 19
Portsmouth 18
Da Nang 17
Chennai 16
Montreal 16
Bari 15
Brooklyn 15
Yubileyny 15
Andover 14
Tianjin 14
Palermo 13
Redwood City 13
Siena 13
Atlanta 12
Daan 12
Johannesburg 12
Miano 12
Haiphong 11
Izmir 11
Philadelphia 11
Rio de Janeiro 11
San José 11
Bangkok 10
Brasília 10
Denver 10
Hillsboro 10
San Francisco 10
Venice 10
Vienna 10
Totale 16.181
Salva come PNG Salva come JPEG
Nome #
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment 397
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 382
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 366
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 358
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 354
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 351
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? 349
Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. 344
A comparative kinetic analysis of proliferation in vitro of con-A-treated splenocytes and syngeneic leukaemia cells. 343
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 339
Metabolic aspects of cell cycle regulation in normal and cancer ceLLS. 337
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 332
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells 328
NGF inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation and cytochrome c release. 321
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 299
Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release 298
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. 297
1,25-dihydroxyvitamin D3 and erk ½ map kinases in a human chronic myeloid leukemia cell line 280
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 278
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 265
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. 264
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. 257
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 255
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence. 254
Cancer stemness and progression: Mitochondria on the stage 250
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. 248
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 239
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 235
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction 234
Cellule, tessuti e malattia - Principi di patologia generale 227
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 223
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 221
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 219
APOPTOSIS - MOLECULAR REGULATION OF CELL DEATH AND HEMATOLOGIC MALIGNANCIES 217
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 215
HYPOXIA SELECTS DRUG-INSENSITIVE PROGENITORS WITHIN CLONAL LEUKAEMIA CELL POPULATIONS 213
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate 211
Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. 209
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 208
ACTIVATION OF ERK5, A MEMBER OF THE MAPK FAMILY, DIFFERENTIALLY REGULATES PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS 205
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 201
Imatinib-mesylate enhances the maintenance of chronic myeloid leukemia stem cell potential in the absence of glucose. 201
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 200
BCR::ABL1 expression in chronic myeloid leukemia cells in low oxygen is regulated by glutamine via CD36-mediated fatty acid uptake 198
Apoptosis: molecular regulation of cell death and hematologic malignancies. 197
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 196
Sensitivity to imatinib of KCL22 chronic myeloid leukemia cell survival/growth and stem cell potential under glucose shortage 196
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKAEMIA CELL LINE CAUSED BY ADMINISTRATION OF TWO HDAC INHIBITORS, VPA AND SAHA 192
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 191
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 191
ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS 189
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 187
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 185
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 185
CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS 184
c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO 184
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. 184
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 178
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 178
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 176
v-raf confers CSF-1-independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation. 174
CHARACTERIZATION OF SIGNALS LINKING THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR TO THE FOCAL ADHESION KINASE 173
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. 172
CITOKINE RECEPTOR SIGNAL TRANSDUCTION MECHANISMS IN IMMUNO-HEMATOPOIETIC CELLS 171
Low Mr Phosphotyrosine Protein Phosphatase Associates and Dephosphorylates p125 Focal Adhesion Kinase, Interfering with Cell Motility and Spreading 170
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 170
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 169
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 169
CSF1 Determines CSF1R Cytoplasmic Nuclear Shuttling in Breast Cancer Cells 166
GLUCOSE AVAILABILITY IN HYPOXIA REGULATES THE SELECTION OF CML PROGENITOR SUBSETS WITH DIFFERENT RESISTANCE TO IMATINIB-MESYLATE 166
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 166
Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells 165
Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. 164
Alterations in CSF-1 receptor expression and protein tyrosine phosphorylation in autonomous mutants of a CSF-1 dependent macrophage cell line. 163
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. 160
Tryptophan availability selectively limits NO-synthase induction in macrophages. 160
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 160
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. 157
Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. 157
TRAIL IS INVOLVED IN HYPOXIA-INDUCED APOPTOSIS OF ACUTE MYELOID LEUKEMIA T(8;21)-POSITIVE CELLS 156
BORTEZOMIB SPECIFICALLY TARGETS A SUBSET OF HYPOXIA-SELECTED CML STEM CELLS 156
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 156
Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. 155
Bortezomib Specifically Targets a Subset of Hypoxia-Selected CML Stem Cells 155
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 155
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 152
ROLE OF ERK5 IN THE SURVIVAL OF MYELOID LEUKEMIA CELLS IN HYPOXIA 151
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 150
ERK5 inhibition elicits cellular senescence in human melanoma cells 149
Environmental restrictions within tumor ecosystems select for a convergent hypoxia-resistant phenotype of cancer stem cells 147
Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. 147
CXCR3 and αEβ7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytes 147
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 144
Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro. 142
Transmodulation of cell surface regulatory molecules via ectodomain shedding. 140
Glucose Availability in Hypoxia Regulates the Selection of CML Progenitor Subsets with Different Resistance to Imatinib-Mesylate 140
Tissue Hypoxia and the Maintenance of Leukemia Stem Cells 140
The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. 138
Functional specificity of cytoplasmic and transmembrane tyrosine kinases: identification of 130- and 75-kilodalton substrates of c-fps/fes tyrosine kinase in macrophages. 135
Tumor angiogenesis: Thrombin and metalloproteinases in focus. 133
Totale 21.255
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.533
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022756 0 0 0 60 48 49 36 60 55 50 154 244
2022/20232.414 215 354 121 193 186 429 326 143 291 16 70 70
2023/2024864 45 82 123 45 66 124 52 181 21 22 68 35
2024/20255.628 199 596 346 888 1.766 766 35 294 229 164 182 163
2025/20265.956 664 750 343 378 710 267 715 280 393 392 160 904
2026/20271.026 171 201 602 52 0 0 0 0 0 0 0 0
Totale 23.711